Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus

NCT02554019 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biotest